type 2 diabetes and semaglutide The FDA requires manufacturers to assess the cardiovascular risk of all new therapies for diabetes. Semaglutide, a glucagon like peptide-1 analogue, lowers blood glucose, but does it increase Semaglutide ⏺Type 2 diabetes mellitus

We do believe these drugs may have the potential to be useful in a wide range of addictive disorders

I now eat when Im hungry, and find that small amounts are quite filling

Pancreatitis risk GLP-1 medications carry a small pancreatitis risk

A 2008 study in British Journal of Clinical Pharmacology found that oral L-citrulline increased plasma L-arginine levels more effectively than L-arginine itself

Super Bowl LIX might be over, but the leftover controversies are still buzzing!This year, a Super Bowl commercial put out by the telehealth company Hims & Hers has been drawing both attention and side-eyes from critics who say the company's promotion of its weight-loss drugs misled consumers by leaving out key information.Hims & Hers, which advertised itself as a service offering inexpensive GLP-1 agonists or semaglutides the class of medications that includes Ozempic and Wegovy, is being criticized heavily

These are in varying phases of preclinical or early clinical study